The North America AI in healthcare market size exceeded USD 1 billion in 2020 and is poised to witness over 44.2% CAGR from 2021 to 2027 driven by the increasing application of artificial intelligence in medical research coupled with the ability to tackle the several constraining medical challenges of traditional time.

North America Artificial Intelligence (AI) in Healthcare Market Size Forecasts 2027

North America Artificial Intelligence (AI) in Healthcare Market Size By Application (Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow, Wearables, Virtual Assistants), Research Report, Country Outlook (U.S., Canada), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021– 2027

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market definition

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; Data sources

1.4.1&nbsp;&nbsp;&nbsp; Secondary

1.4.1.1&nbsp;&nbsp;&nbsp; Paid sources

1.4.1.2&nbsp;&nbsp;&nbsp; Unpaid sources

1.4.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; North America healthcare artificial intelligence industry 3600 synopsis, 2016 - 2027

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

Chapter 3&nbsp;&nbsp;&nbsp;North America Healthcare Artificial Intelligence Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2016 - 2027

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Rising adoption of healthcare artificial intelligence in research areas

3.3.1.2&nbsp;&nbsp;&nbsp; Increasing range of future applications

3.3.1.3&nbsp;&nbsp;&nbsp; Advancements in big data analytics

3.3.1.4&nbsp;&nbsp;&nbsp; Favorable funding scenario

3.3.1.5&nbsp;&nbsp;&nbsp; Potential to increase quality of care delivery

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; High initial capital requirement

3.3.2.2&nbsp;&nbsp;&nbsp; Large scale human unemployment

3.3.2.3&nbsp;&nbsp;&nbsp; Difficulty in deployment

3.4&nbsp;&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive landscape, 2020

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;North America Healthcare Artificial Intelligence Market, By Application

4.1&nbsp;&nbsp;&nbsp; Market trends

4.2&nbsp;&nbsp;&nbsp; Medical imaging &amp; diagnosis

4.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Drug discovery

4.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Therapy planning

4.4.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Hospital workflow

4.5.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.6&nbsp;&nbsp;&nbsp; Wearables

4.6.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.7&nbsp;&nbsp;&nbsp; Virtual assistants

4.7.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.8&nbsp;&nbsp;&nbsp; Others

4.8.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;North America Healthcare Artificial Intelligence Market, By Country

5.1&nbsp;&nbsp;&nbsp; Market trends

5.2&nbsp;&nbsp;&nbsp; U.S.

5.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Canada

5.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Company Profiles

6.1&nbsp;&nbsp;&nbsp; AiCure

6.1.1&nbsp;&nbsp;&nbsp; Business overview

6.1.2&nbsp;&nbsp;&nbsp; Financial data

6.1.3&nbsp;&nbsp;&nbsp; Product landscape

6.1.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.2&nbsp;&nbsp;&nbsp; APIXIO, Inc

6.2.1&nbsp;&nbsp;&nbsp; Business overview

6.2.2&nbsp;&nbsp;&nbsp; Financial data

6.2.3&nbsp;&nbsp;&nbsp; Product landscape

6.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.3&nbsp;&nbsp;&nbsp; Atomwise, Inc.

6.3.1&nbsp;&nbsp;&nbsp; Business overview

6.3.2&nbsp;&nbsp;&nbsp; Financial data

6.3.3&nbsp;&nbsp;&nbsp; Product landscape

6.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.4&nbsp;&nbsp;&nbsp; Butterfly Network, Inc.

6.4.1&nbsp;&nbsp;&nbsp; Business overview

6.4.2&nbsp;&nbsp;&nbsp; Financial data

6.4.3&nbsp;&nbsp;&nbsp; Product landscape

6.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.5&nbsp;&nbsp;&nbsp; Cyrcadia Health Inc.

6.5.1&nbsp;&nbsp;&nbsp; Business overview

6.5.2&nbsp;&nbsp;&nbsp; Financial data

6.5.3&nbsp;&nbsp;&nbsp; Product landscape

6.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.6&nbsp;&nbsp;&nbsp; Enlitic, Inc.

6.6.1&nbsp;&nbsp;&nbsp; Business overview

6.6.2&nbsp;&nbsp;&nbsp; Financial data

6.6.3&nbsp;&nbsp;&nbsp; Product landscape

6.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.7&nbsp;&nbsp;&nbsp; IBM (Watson Health)

6.7.1&nbsp;&nbsp;&nbsp; Business overview

6.7.2&nbsp;&nbsp;&nbsp; Financial data

6.7.3&nbsp;&nbsp;&nbsp; Product landscape

6.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.8&nbsp;&nbsp;&nbsp; iCarbonX

6.8.1&nbsp;&nbsp;&nbsp; Business overview

6.8.2&nbsp;&nbsp;&nbsp; Financial data

6.8.3&nbsp;&nbsp;&nbsp; Product landscape

6.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.9&nbsp;&nbsp;&nbsp; Insilico Medicine Inc

6.9.1&nbsp;&nbsp;&nbsp; Business overview

6.9.2&nbsp;&nbsp;&nbsp; Financial data

6.9.3&nbsp;&nbsp;&nbsp; Product landscape

6.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.10&nbsp;&nbsp;&nbsp; NVIDIA Corporation

6.10.1&nbsp;&nbsp;&nbsp; Business overview

6.10.2&nbsp;&nbsp;&nbsp; Financial data

6.10.3&nbsp;&nbsp;&nbsp; Product landscape

6.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.11&nbsp;&nbsp;&nbsp; Modernizing Medicine

6.11.1&nbsp;&nbsp;&nbsp; Business overview

6.11.2&nbsp;&nbsp;&nbsp; Financial data

6.11.3&nbsp;&nbsp;&nbsp; Product landscape

6.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.12&nbsp;&nbsp;&nbsp; OmeCare Inc.

6.12.1&nbsp;&nbsp;&nbsp; Business overview

6.12.2&nbsp;&nbsp;&nbsp; Financial data

6.12.3&nbsp;&nbsp;&nbsp; Product landscape

6.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.13&nbsp;&nbsp;&nbsp; Sens.ly Inc.

6.13.1&nbsp;&nbsp;&nbsp; Business overview

6.13.2&nbsp;&nbsp;&nbsp; Financial data

6.13.3&nbsp;&nbsp;&nbsp; Product landscape

6.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.14&nbsp;&nbsp;&nbsp; Sophia Genetics

6.14.1&nbsp;&nbsp;&nbsp; Business overview

6.14.2&nbsp;&nbsp;&nbsp; Financial data

6.14.3&nbsp;&nbsp;&nbsp; Product landscape

6.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.15&nbsp;&nbsp;&nbsp; Welltok

6.15.1&nbsp;&nbsp;&nbsp; Business overview

6.15.2&nbsp;&nbsp;&nbsp; Financial data

6.15.3&nbsp;&nbsp;&nbsp; Product landscape

6.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.16&nbsp;&nbsp;&nbsp; Zebra Medical Vision Ltd

6.16.1&nbsp;&nbsp;&nbsp; Business overview

6.16.2&nbsp;&nbsp;&nbsp; Financial data

6.16.3&nbsp;&nbsp;&nbsp; Product landscape

6.16.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.17&nbsp;&nbsp;&nbsp; Johnson and Johnson

6.17.1&nbsp;&nbsp;&nbsp; Business overview

6.17.2&nbsp;&nbsp;&nbsp; Financial data

6.17.3&nbsp;&nbsp;&nbsp; Product landscape

6.17.4&nbsp;&nbsp;&nbsp; Strategic outlook 
&nbsp;